The global clinical nutrition market is experiencing significant growth and its value is expected to increase from USD 47.4 billion in 2022 to USD 85.2 billion by 2032, increasing by 6.2% during the forecast period 2022-2032. Record CAGR. Driving this growth is the increasing prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders, increasing the need for nutritional support. Additionally, the growing elderly population, especially in regions such as North America and Europe, is contributing to the demand for clinical nutrition, as older adults often require specialized nutritional interventions.
Recent developments in the market include the introduction of innovative products aimed at improving the nutritional value and taste of clinical nutritional formulations. For example, in March 2021, Kate Farms launched a new product to address nutritional deficiencies in patients with chronic diseases.
Challenges in the clinical nutrition market are primarily due to the stringent regulatory framework governing product approval and commercialization. High compliance costs and the need for rigorous clinical trials can prevent new players from entering the market. Despite these challenges, the market continues to expand, supported by technological advances in parenteral and enteral nutrition products that have improved safety and efficacy.
Overall, the clinical nutrition market is expected to witness robust growth due to rising health awareness, advancements in product formulations, and supportive government initiatives aimed at strengthening global healthcare infrastructure.
Important points
- The clinical nutrition market is $85.2 billion By 2032, growing at an annual rate 6.20%.
- The oral segment is leading the market due to the rise in chronic diseases, and the enteral segment is also showing rapid growth.
- The oncology application segment is experiencing the highest CAGR due to the increase in diabetes patients and aging population.
- Pediatric nutrition accounts for the largest market share and is also expected to have the highest projected CAGR.
- Aging global populations require clinical nutrition for effective chronic disease management.
- The limited uptake of the product in developing countries is due to limited healthcare resources and affordability issues.
- Online retail is gaining importance as consumers prefer convenience, driving sales of clinical nutrition products.
- The rise in metabolic disorders and the impact of COVID-19 has increased the demand for clinical nutrition products.
- In 2022, North America Dominate the market and hold the highest revenue share 38%.
- Asia Pacific is expected to grow at the fastest CAGR from 2023 to 2032.
Get a sample PDF report: https://market.us/report/clinical-nutrition-market/request-sample/
Key segments of the clinical nutrition market
By route of administration
By application
- metabolic disorders
- malnutrition
- digestive diseases
- cancer
- neurological disease
- Other diseases
By end user
- adult
- Child
- For the elderly
Major Regions
- North America (USA, Canada, Mexico)
- Western Europe (Germany, France, United Kingdom, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Northern Europe, and other Western Europe)
- Eastern Europe (Russia, Poland, Czech Republic, Greece, and other Eastern European countries)
- APAC (China, Japan, South Korea, India, Australia and New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, and other Asia-Pacific regions)
- Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
- Middle East and Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)
Purchase directly: https://market.us/purchase-report/?report_id=97087
Analysis of major companies
B. Braun Melsungen AG is a leading player in the clinical nutrition market, offering a wide range of nutritional products aimed at improving patient outcomes. The company’s portfolio includes enteral and parenteral nutrition solutions designed to meet the diverse needs of patients with chronic illnesses, critical illnesses and postoperative care needs. B. Braun has established itself as a leader in its field through a focus on innovation and quality, and continues to expand its product range to include advanced formulations that improve patient recovery and overall health outcomes. doing. The company’s commitment to research and development ensures the continued development of effective and safe nutritional products.
Perrigo Company plc operates in the clinical nutrition sector by offering a range of dietary supplements and medical foods tailored to specific health conditions. Known for its high quality standards, Perrigo offers products that support the dietary management of patients with chronic diseases, malnutrition and other medical conditions requiring specialized nutrition. The company’s extensive research and development efforts are focused on creating innovative solutions that address the evolving needs of the clinical nutrition market, ensuring better patient care and improved health outcomes.
Hero Nutritionals Inc. specializes in manufacturing nutritional supplements, including vitamin gummies, for both children and adults. In the clinical nutrition field, Hero Nutritionals offers products that support overall health, address nutritional deficiencies and strengthen the immune system. The company has earned a trusted reputation in the industry due to its commitment to high-quality ingredients and innovative delivery methods. Hero Nutritionals products are designed to be effective and enjoyable to consume, encouraging adherence to nutritional plans.
Fresenius Kabi AG is a global leader in clinical nutrition, offering a wide range of enteral and parenteral nutrition products. The company’s solutions are designed to support patients with serious or chronic illnesses and those recovering from surgery. Fresenius Kabi is focused on providing high quality, innovative nutritional therapies that improve patient outcomes and quality of life. With a focus on research and development, the company continually enhances its product lineup to meet the growing demands of the healthcare sector.
Pfizer Inc. is serving the clinical nutrition market by developing and delivering medical foods and nutritional supplements that address specific health needs. The company’s products are designed to support patients with a variety of health conditions, including those who require nutritional support while undergoing treatment or recovery from chronic illness. Pfizer’s commitment to scientific research and innovation ensures the development of high-quality, effective nutritional solutions that enhance the health and well-being of patients. The company’s extensive global reach enables it to impact a wide range of patients around the world.
Key players in the clinical nutrition market:
- Braun Melsungen AG
- perrigo company
- Hero Nutritionals Co., Ltd.
- Fresenius Kabi AG
- Pfizer Japan Inc
- Hospira Co., Ltd.
- Abbott Laboratories, Inc.
- Reckitt Benckiser Group PLC
- Other key players
Scope of Clinical Nutrition Market Report >> Market value (2022): USD 47.4 billion || Projected revenue (2032): USD 85.2 billion || CAGR (2023-2032): 6.2% || Base year estimate: 2023 || Historical period: 2019 From 2022 || Forecast period: 2024-2033.
For more information regarding the report: https://market.us/report/clinical-nutrition-market/#inquiry
About Market.US
Market.US is known for its comprehensive market research and analysis, providing customized reports to customers worldwide. We specialize in a variety of areas and provide strategic insights and detailed market forecasts to help businesses make informed decisions. Market.US focuses on innovation and accuracy, supports customers in over 126 countries, maintains a high repeat business rate, and emphasizes our commitment to quality and customer satisfaction. Their team excels in providing superior research services and ensures that no detail is overlooked in any target market.
Contact details
Market.us (provided by Prudour Pvt. Ltd.)
Contact number: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/
View more trend reports
Oligonucleotide synthesis market is estimated to reach USD 36.3 billion by 2033 at a CAGR of approximately 17.1%
The economic forecast for the mental health app market is to soar to $23.8 billion by 2033, with a compound annual growth rate of 16.9%
Pharmaceutical excipients market trends projected to be valued at US$ 11.8 billion by 2033, growing at a CAGR of 5.8%
Urology equipment market expansion: expected to reach USD 67.7 billion by 2033
The tissue engineering market is expected to reach USD 35.2 billion by 2032, growing at a CAGR of approximately 11.4%
